Since APE1 has emerged as an excellent target for sensitizing tumor cells to chemotherapy [50], [51], [52], [53], APE1 DNA-repair and redox-inhibition may be used as a promising strategy for liver cancer treatment [34], [54]. The gene discussed is APEX1; the disease is liver cancer.